(2S,4S,4'R)-2',2'-Dimethyl-[4,4'-bi-1,3-dioxolane]-2-methanol 2-Benzoate is an intermediate used in the synthesis of Troxacitabine (T805580), which is a nucleoside analogue with potential anticancer activity. Troxacitabine have been studied in patients with refractory lymphoproliferative diseases.